MassDevice Earnings Roundup
FDA approves Nevro’s Senza pain device ahead of schedule
Siemens misses profit expectations, cuts more jobs
BD’s Q2 earnings top forecast, outlook affirmed
Sorin hopes Perceval valve will rescue flat results
Coloplast tumbles on missed Q2 expectations
Abiomed surges to another all-time high on 2014 results
NuVasive gains on Q1 results, new platform launch
NuVasive Inc. (NSDQ:NUVA) shares are up today on a 1st-quarter swing to black ink and the launch of its 1st major new platform in a decade.